SCIREX Corporation today announced the appointment of Dr. Samer E. Kaba to the position of Vice President Clinical Research and Medical Management.
Horsham, PA, May 2, 2005 -- SCIREX Corporation today announced the appointment of Dr. Samer E. Kaba to the position of Vice President Clinical Research and Medical Management. Dr. Kaba will direct the operations of the Medical Management and Safety group, monitor the medical and safety aspects of projects managed by the company and provide medical and safety consulting services to Sponsors, clinical sites and project teams.
Dr. Kaba joins SCIREX from PRA International, where most recently he was Senior Director, CNS, Global Product Development Services, responsible for formulating clinical development strategies and providing consultative and life cycle management advisory services for new therapies.
Dr. Kaba is a graduate of the Damascus University School of Medicine and did residency training in internal medicine and neurology at the State University of New York (SUNY), Buffalo. He completed fellowships in neuro-immunology/multiple sclerosis at SUNY, and in neuro-oncology at the University of Texas M. D. Anderson Cancer Center in Houston, where he also served as a faculty member. Dr. Kaba currently holds an adjunct faculty position at the Department of Neurology at Emory University in Atlanta. He served as the Director of Research at the Shepherd MS Center in Atlanta and as Assistant Professor at the University of Arkansas in Little Rock, where he also managed a private neurology practice. Dr. Kaba is certified by the American Board of Psychiatry and Neurology and has multiple scientific publications on topics relating to CNS diseases and disorders. He holds professional memberships in the American Academy of Neurology, the Society for Neuro-Oncology, the American Society of Clinical Oncology, and the American Academy of Pharmaceutical Physicians.
"This is a significant appointment for SCIREX," said John Whalen, M.D., General Manager, Clinical Development Services. "Since excellence in clinical trial design and patient safety are at the heart of the services we provide our clients, Dr. Kaba's academic achievements, his experience as a clinician and his substantial industry experience make him superbly qualified to lead these critical areas of our operations."
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.